On Thursday, genetics-led consumer healthcare company 23andMe Holding Co. (NASDAQ:ME) announced a business restructuring to ...

The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease.

Explore how the genetic testing industry is transforming healthcare through precision medicine ensuring patient privacy and ...

The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...

Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...

DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will ...

We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...

23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...